Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ambagon Therapeutics is a biotechnology company focused on developing novel small-molecule therapies targeting intrinsically disordered proteins. Leveraging a proprietary molecular glue platform, the company stabilizes protein interactions—particularly via 14-3-3 adaptor proteins—to unlock previously undruggable targets. With strong expertise in structural biology and protein-protein interactions, Ambagon is advancing a pi...
Ambagon Therapeutics is a biotechnology company focused on developing novel small-molecule therapies targeting intrinsically disordered proteins. Leveraging a proprietary molecular glue platform, the company stabilizes protein interactions—particularly via 14-3-3 adaptor proteins—to unlock previously undruggable targets. With strong expertise in structural biology and protein-protein interactions, Ambagon is advancing a pipeline of first-in-class therapies, primarily in oncology, addressing significant unmet medical needs.

List your booth number for exhibitions, ask us